Glimelius, B <br/><br/>
A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  May 2010 
 - 1020-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdp521  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Aged<br/>Aged, 80 and over<br/>Carcinoembryonic Antigen--blood<br/>Colorectal Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Indoles--therapeutic use<br/>L-Lactate Dehydrogenase--blood<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Prognosis<br/>Protein Kinase C--antagonists & inhibitors<br/>Protein Kinase C beta<br/>Tissue Distribution